Effect of dilutive RSUs and PSUs (in shares)
HCA Healthcare Effect of dilutive RSUs and PSUs (in shares) increased by 1187.4% to $3.06M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.4%, from $2.50M to $3.06M. Over 3 years (FY 2021 to FY 2025), Effect of dilutive RSUs and PSUs (in shares) shows a downward trend with a -17.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase indicates higher potential dilution for existing shareholders, often resulting from increased equity-based compensation grants.
Detailed definition
The number of additional shares that would be issued if all dilutive securities, such as restricted stock units and perf...
Peer comparison
Standardized metric for all public companies to assess the impact of equity compensation on share dilution.
other_weighted_average_number_diluted_shares_outstanding_a58f4fHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.44M | $5.96M | $237.00K | $4.93M | $3.53M | $3.89M | $199.00K | $4.05M | $3.70M | $4.25M | $6.00K | $3.58M | $2.92M | $3.15M | $2.50M | $2.74M | $3.29M | $238.00K | $3.06M |
| QoQ Change | — | +34.1% | -96.0% | >999% | -28.3% | +10.2% | -94.9% | >999% | -8.6% | +14.8% | -99.9% | >999% | -18.6% | +8.2% | -20.6% | +9.3% | +20.2% | -92.8% | >999% |
| YoY Change | — | — | — | — | -20.4% | -34.6% | -16.0% | -17.8% | +4.8% | +9.2% | -97.0% | -11.6% | -21.3% | -25.8% | -30.1% | -6.1% | +4.3% | — | +22.4% |
Effect of dilutive RSUs and PSUs (in shares) at Other Companies
Frequently Asked Questions
- What is HCA Healthcare's effect of dilutive rsus and psus (in shares)?
- HCA Healthcare (HCA) reported effect of dilutive rsus and psus (in shares) of $3.06M in Q1 2026.
- How has HCA Healthcare's effect of dilutive rsus and psus (in shares) changed year-over-year?
- HCA Healthcare's effect of dilutive rsus and psus (in shares) increased by 22.4% year-over-year, from $2.50M to $3.06M.
- What is the long-term trend for HCA Healthcare's effect of dilutive rsus and psus (in shares)?
- Over 3 years (2021 to 2025), HCA Healthcare's effect of dilutive rsus and psus (in shares) has grown at a -17.9% compound annual growth rate (CAGR), from $15.83M to $8.77M.
- What does effect of dilutive rsus and psus (in shares) mean?
- The potential increase in shares from employee stock-based compensation awards.